Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.
Saved in:
| Title: | Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy. |
|---|---|
| Authors: | Baldacci S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Brea EJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Facchinetti F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Li Z; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Ngo K; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Malhotra S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Booker MA; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Chakravarti S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hinchey C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Lococo F; Università Cattolica del Sacro Cuore, Rome, Italy.; Thoracic Surgery Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., D'Agnelli S; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Gnetti L; Pathology Unit, University Hospital of Parma, Parma, Italy., Campanini N; Department of Medicine and Surgery, University of Parma, Parma, Italy., Leonetti A; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Feng WW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hartley AV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Locquet MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Fournel L; Thoracic Surgery Department, Hôpital Cochin AP-HP Centre, Université Paris Cité, Paris, France., Alifano M; Thoracic Surgery Department, Hôpital Cochin AP-HP Centre, Université Paris Cité, Paris, France., Mansuet-Lupo A; Department of Pathology, Hôpital Cochin AP-HP Centre, Université Paris Cité, Paris, France., Saldanha A; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Haller W; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Zasadil LM; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Zielinska M; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Bui K; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Tuladhar B; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Lizotte PH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Ivanova EV; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Sequist LV; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Gokhale PC; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Smith EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Parker Institute for Cancer Immunotherapy, San Francisco, California., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Parker Institute for Cancer Immunotherapy, San Francisco, California. |
| Source: | Cancer discovery [Cancer Discov] 2025 Nov 03; Vol. 15 (11), pp. 2235-2250. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40762432 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Baldacci+S%22">Baldacci S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Brea+EJ%22">Brea EJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Facchinetti+F%22">Facchinetti F</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ngo+K%22">Ngo K</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Malhotra+S%22">Malhotra S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Booker+MA%22">Booker MA</searchLink>; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tolstorukov+MY%22">Tolstorukov MY</searchLink>; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Chakravarti+S%22">Chakravarti S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hinchey+C%22">Hinchey C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Mahadevan+NR%22">Mahadevan NR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lococo+F%22">Lococo F</searchLink>; Università Cattolica del Sacro Cuore, Rome, Italy.; Thoracic Surgery Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22D'Agnelli+S%22">D'Agnelli S</searchLink>; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Gnetti+L%22">Gnetti L</searchLink>; Pathology Unit, University Hospital of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Campanini+N%22">Campanini N</searchLink>; Department of Medicine and Surgery, University of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Leonetti+A%22">Leonetti A</searchLink>; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Feng+WW%22">Feng WW</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tsai+JA%22">Tsai JA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hartley+AV%22">Hartley AV</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Locquet+MA%22">Locquet MA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Fournel+L%22">Fournel L</searchLink>; Thoracic Surgery Department, Hôpital Cochin AP-HP Centre, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Alifano+M%22">Alifano M</searchLink>; Thoracic Surgery Department, Hôpital Cochin AP-HP Centre, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mansuet-Lupo+A%22">Mansuet-Lupo A</searchLink>; Department of Pathology, Hôpital Cochin AP-HP Centre, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Saldanha+A%22">Saldanha A</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Haller+W%22">Haller W</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zasadil+LM%22">Zasadil LM</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zielinska+M%22">Zielinska M</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bui+K%22">Bui K</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tuladhar+B%22">Tuladhar B</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lizotte+PH%22">Lizotte PH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ivanova+EV%22">Ivanova EV</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sequist+LV%22">Sequist LV</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Gokhale+PC%22">Gokhale PC</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Paweletz+CP%22">Paweletz CP</searchLink>; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Smith+EL%22">Smith EL</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Parker Institute for Cancer Immunotherapy, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Jänne+PA%22">Jänne PA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Barbie+DA%22">Barbie DA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Parker Institute for Cancer Immunotherapy, San Francisco, California. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2025 Nov 03; Vol. 15 (11), pp. 2235-2250. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40762432 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2159-8290.CD-24-1515 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2235 Titles: – TitleFull: Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Baldacci S – PersonEntity: Name: NameFull: Brea EJ – PersonEntity: Name: NameFull: Facchinetti F – PersonEntity: Name: NameFull: Li Z – PersonEntity: Name: NameFull: Ngo K – PersonEntity: Name: NameFull: Malhotra S – PersonEntity: Name: NameFull: Booker MA – PersonEntity: Name: NameFull: Tolstorukov MY – PersonEntity: Name: NameFull: Chakravarti S – PersonEntity: Name: NameFull: Hinchey C – PersonEntity: Name: NameFull: Mahadevan NR – PersonEntity: Name: NameFull: Lococo F – PersonEntity: Name: NameFull: D'Agnelli S – PersonEntity: Name: NameFull: Gnetti L – PersonEntity: Name: NameFull: Campanini N – PersonEntity: Name: NameFull: Leonetti A – PersonEntity: Name: NameFull: Feng WW – PersonEntity: Name: NameFull: Tsai JA – PersonEntity: Name: NameFull: Hartley AV – PersonEntity: Name: NameFull: Locquet MA – PersonEntity: Name: NameFull: Fournel L – PersonEntity: Name: NameFull: Alifano M – PersonEntity: Name: NameFull: Mansuet-Lupo A – PersonEntity: Name: NameFull: Saldanha A – PersonEntity: Name: NameFull: Haller W – PersonEntity: Name: NameFull: Zasadil LM – PersonEntity: Name: NameFull: Zielinska M – PersonEntity: Name: NameFull: Bui K – PersonEntity: Name: NameFull: Tuladhar B – PersonEntity: Name: NameFull: Lizotte PH – PersonEntity: Name: NameFull: Ivanova EV – PersonEntity: Name: NameFull: Sequist LV – PersonEntity: Name: NameFull: Gokhale PC – PersonEntity: Name: NameFull: Paweletz CP – PersonEntity: Name: NameFull: Smith EL – PersonEntity: Name: NameFull: Jänne PA – PersonEntity: Name: NameFull: Barbie DA IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 11 Text: 2025 Nov 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2159-8290 Numbering: – Type: volume Value: 15 – Type: issue Value: 11 Titles: – TitleFull: Cancer discovery Type: main |
| ResultId | 1 |